missing translation for 'onlineSavingsMsg'
Learn More

STEMCELL Technologies LY2228820 (Dimesylate)

Product Code. 17110342
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 mg
5 mg
Unit Size:
1mg
5mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
17110342 5 mg 5mg
17100342 1 mg 1mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Product Code. 17110342 Supplier STEMCELL Technologies Supplier No. 74164
 Restricted Item
Estimated Shipment: 17-08-2026
Add to basket
Add to basket
This item is not returnable. View return policy

p38 MAP kinase (MAPK) inhibitor

  • LY2228820 is a trisubstituted imidazole derivative and a potent inhibitor of the α- and β-isoforms of p38 MAP kinase (MAPK) in vitro (IC50 = 5.3 and 3.2 nM, respectively) with anti-inflammatory and anti-neoplastic activities (Campbell et al.) This product is supplied as the dimesylate salt of the molecule
  • Combined with other small molecule inhibitors such as Rapamycin (Catalog #73362) and SR1 (Catalog #72342; Li et al.) or SB203580 (Catalog #72222), Vx702, and BIRB-796 (Catalog #72682), enhances the self-renewal of cord blood-derived hematopoietic stem cells (Baudet et al.)
  • By inhibiting p38 MAPK, which is highly expressed in human cancers, LY2228820 is potent and selective at inhibiting tumor growth in animal models of a variety of human cancers (Campbell et al.)

Specifications

CAS 862507-23-1
Synonym Ralimetinib Mesylate; LSN2322600
Quantity 5 mg
Molecular Formula C24H29FN6 · 2CH3SO3H
Purity ≥98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.